Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR - Takeaways - MDSpire

Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR

  • By

  • Dario Grassini

  • Karl-Patrik Kresoja

  • Jennifer von Stein

  • Vera Fortmeier

  • Christoph Pauschinger

  • Wolfgang Rottbauer

  • Mohammad Kassar

  • Bjoern Goebel

  • Paolo Denti

  • Paul Achouh

  • Tienush Rassaf

  • Manuel Barreiro-Perez

  • Peter Boekstegers

  • Andreas Rück

  • Monika Zdanyte

  • Marianna Adamo

  • Flavien Vincent

  • Philipp Schlegel

  • Sebastian Rosch

  • Mirjam G. Wild

  • Christian Besler

  • Stefan Toggweiler

  • Stephanie Brunner

  • Julia Grapsa

  • Tiffany Patterson

  • Holger Thiele

  • Tobias Kister

  • Giuseppe Tarantini

  • Giulia Masiero

  • Marco De Carlo

  • Cristina Giannini

  • Fabian Voss

  • Amin Polzin

  • Antonio Popolo Rubbio

  • Francesco Bedogni

  • Thorald Stolte

  • Thomas Nestelberger

  • Tomás Benito-González

  • Enrique Sánchez-Muñóz

  • Martijn Vrijkorte

  • Martin Swaans

  • Mathias H. Konstandin

  • Eric Van Belle

  • Marco Metra

  • Tobias Geisler

  • Rodrigo Estévez-Loureiro

  • Amir Abbas Mahabadi

  • Nicole Karam

  • Francesco Maisano

  • Philipp Lauten

  • Mirjam Kessler

  • Daniel Kalbacher

  • Volker Rudolph

  • Christos Iliadis

  • Philipp Lurz

  • Fabien Praz

  • Lukas Stolz

  • Jörg Hausleiter

  • May 18, 2026

  • 0 min

Share

  • 1

    Tricuspid regurgitation (TR) is prevalent among elderly patients, and transcatheter edge-to-edge repair (T-TEER) is an effective treatment for severe TR.

  • 2

    Patients with prior cardiac surgery (PCS) represent a significant subgroup undergoing T-TEER, with 27.2% of the study population having a history of PCS.

  • 3

    Residual TR severity post-T-TEER was significantly higher in patients with PCS compared to those without, indicating reduced procedural success.

  • 4

    At follow-up, patients with PCS showed less improvement in TR reduction compared to non-PCS patients, with 19.6% having residual TR ≥ 3+.

  • 5

    Thirty-day mortality rates were similar between patients with and without PCS, suggesting that prior surgery does not increase immediate procedural risk.

Original Source(s)

Related Content